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523Exiting the Outside World
for Cross-Presentation
How are extracellular proteins cross-presented on
MHC class I molecules? In this issue of Immunity,
Ackerman et al. (2006) demonstrate that the ER-
associated degradation (ERAD) export pathway
operates in the phagosomes of dendritic cells and
transfers antigens into the MHC class I pathway.
In most situations MHC class I molecules display pep-
tides that are generated exclusively from a cell’s own
proteins. This is because, in most cells, proteins in the
extracellular environment are unable to gain access to
the cytosolic proteases that generate peptides for pre-
sentation on MHC class I molecules. These mecha-
nisms allow CD8+ T cells to identify cells that are synthe-
sizing abnormal proteins, e.g., from viral infection or
mutations, and to selectively eliminate them while spar-
ing adjacent healthy cells. However, a surprising excep-
tion to this rule was discovered in 1976 when Bevan
found that in mice transplanted with allogeneic cells, ef-
fector CD8+ T cells that were specific for antigens from
the transplant presented on autologous (host) MHC
molecules were generated (Bevan, 1976). This peculiar
phenomenon was termed ‘‘cross-priming’’ or ‘‘cross-
presentation.’’ In 1990, the cellular basis for cross-pre-
sentation was elucidated with the finding that certain
bone-marrow-derived cells had the unique capability
to internalize antigens from the environment and
present them as peptides bound to MHC class I mole-
cules (Rock et al., 1990); these cross-presenting cells
were subsequently identified as dendritic cells and
macrophages.
We now appreciate that cross-presentation plays
a key role in the immune surveillance of peripheral tis-
sues. Naı¨ve T cells don’t traffic into peripheral tissues
and therefore can’t directly detect viral infections or
cancers in these sites. Moreover, even if they did, the
cells they would encounter lack the costimulatory mol-
ecules that are essential for stimulating naı¨ve T cells.
Therefore, CD8+ T cell responses cannot be initiated in
the primary site of most cancers and viral infections.
However, dendritic cells in these sites can acquire anti-
gens from the abnormal cells and then migrate to sec-
ondary lymphoid organs, where they use their cross-
presentation mechanisms and costimulatory molecules
to initiate a CD8+ T cell response. Thus, cross-presenta-
tion plays an essential role in surveying tissues for the
presence of tumors and tissue-specific viral infections
and reporting their presence to naı¨ve CD8+ T cells in
ways that initiate an immune response (Rock and Shen,
2005).
If most cells only present their own antigens, how do
dendritic cells accomplish this unusual feat of acquiring
the antigens from other cells and presenting them on
MHC class I molecules? Immature dendritic cells arephagocytic and rapidly ingest dying cells and their de-
bris. This is one of the mechanisms by which they ac-
quire antigens from cancers and virally infected cells.
Once in phagosomes, antigens can be cross-presented
by at least two pathways. In one, the presented peptides
are generated in the vacuole itself by endosomal prote-
ases, particularly cathepsin S. However, in a second
and even more efficient pathway, particulate antigen is
transferred from phagosomes into the cytosol (Kovac-
sovics-Bankowski and Rock, 1995). Once in the cytosol,
the antigen is processed through the proteasome path-
way and presented like any other cellular protein (Fig-
ure 1). Soluble antigens can also be translocated into
the cytosol and cross-presented, but much less effi-
ciently than particulate ones. In this latter situation, it is
presently unclear whether soluble antigens are trans-
ferred to the cytosol directly from endosomes or after
retrograde transport through the secretory pathway to
the endoplasmic reticulum (ER) (Ackerman et al., 2005).
The discovery of this phagosome-to-cytosol pathway
of cross-presentation was surprising because there was
no known mechanism to transfer internalized proteins
across a phagosomal membrane. A potential insight
into this process was made when the composition of
phagosomes was analyzed by mass spectrometry and
unexpectedly revealed a number of proteins that nor-
mally reside in the ER; such proteins included all of
the components of the MHC class I pathway (TAP,
Tapasin, MHC class I molecules, and various chaper-
ones) (Houde et al., 2003). This led to the concept that
the ER fuses with phagosomes and in this process do-
nates many of its molecules that contribute to cross-
presentation.
One of the ER-resident molecules found in phago-
somes was Sec61. This is the channel through which
membrane and secreted proteins are cotranslationally
transported from the cytosol into the lumen of the ER.
Of interest to cross-presentation, Sec61 also transports
proteins in the opposite direction, and this process
plays a major role in transferring ER-luminal proteins
into the cytosol for degradation by proteasomes, a
process called ER-associated degradation (ERAD)
(Romisch, 2005). Thus, the presence of Sec61 in
phagosomes provided a potential mechanism for the
phagosome-to-cytosol transfer of antigens for cross-
presentation. However, although this was an interesting
hypothesis, there was no direct evidence that Sec61
actually performed this function. Moreover, several
groups subsequently suggested that the finding of ER
components in phagosomes was an experimental arti-
fact and that ER-phagosomal fusion did not occur
(Touret et al., 2005).
In the present issue of Immunity, Ackerman et al. cast
new light on these unresolved issues (Ackerman et al.,
2006). First, to address whether resident ER-compo-
nents are present in phagosomes, they fed a den-
dritic-like cell microspheres that contained on their
surface a polypeptide that contained an NXS/T se-
quence that directs N-linked glycosylation. Ordinarily,
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524Figure 1. Model of the Phagosome-to-Cytosol Cross-Presentation Pathway
Extracellular antigens are internalized into phagosomes of dendritic cells. These phagosomes acquire ER components including Sec61, TAP,
Tapasin, chaperones, and MHC class I molecules. Although internalized antigen would be retained in the endocytic vacuoles in most other kinds
of cells, in dendritic cells Sec61 serves as a channel that with cytosolic p97 exports some of the internalized antigen from the phagosome into the
cytosol in an ERAD-like pathway. Once in the cytosol, the exported antigen is hydrolyzed by proteasomes into oligopeptides, some of which are
then transported by TAP to MHC class I molecules in the ER or phagosome. The peptide-MHC class I complexes are then transported to the cell
surface for cross presentation to CD8 T cells. Other pathways where cross-presented peptides are generated in phagosomes or exogenous sol-
uble antigen may be transported to the ER for export to the cytosol are not shown for clarity.N-linked glycosylation occurs exclusively inside the ER.
However, when the beads were recovered from phago-
somes of the dendritic-like cells, they had been glycosy-
lated. Moreover, this process was inhibited by tunico-
mycin, an agent that selectively blocks N-linked
glycosylation in the ER, implying that the same glycosyl
transferase was in the ER and phagosomes. Control ex-
periments indicated that the beads were glycosylated in
phagosomes rather than during the purification proce-
dure. These data provide strong evidence that phago-
somes in dendritic cells contain what was previously
thought to be ER-resident protein; the data do not ad-
dress whether these proteins arrived in phagsosomes
by ER fusion or some other transport mechanism.
In another set of experiments, the dendritic-like cells
were incubated with Pseudomonas aeruginosa Exo-
toxin A, an agent that among other things inhibits
Sec61. This treatment blocked the ability of an exoge-
nously added polypeptide (ICP47(1-35)) to inhibit a
cytosolic target (the cytosolic domains of TAP). This
provided evidence that Sec61 was involved in the trans-
location of the exogenous peptide into the cytosol and
that exogenous Exotoxin A could be used as a tool to
probe the role of Sec61 in this transport process. A
key experiment then showed that Exotoxin A inhibitedthe ability of dendritic-like cells to cross-present solu-
ble ovalbumin. A control experiment showed that this
inhibition was not due to the well-known effect of Exo-
toxin A of ADP-ribosylating elongation factor 2 and
blocking protein synthesis. Moreover, another key ex-
periment showed that transfection of a dominant-neg-
ative form of p97, a molecule that is needed for retro-
grade transport of proteins from the ER to the cytosol
through Sec61, also reduced the cross-presentation
of ovalbumin. Importantly, this inhibition of cross-pre-
sentation was selective because Exotoxin A and dom-
inant-negative p97 did not inhibit the presentation of
endogenously expressed cytosolic ovalbumin. There-
fore, the data strongly suggest that Sec61 and p97
play an essential role in cross-presentation of soluble
ovalbumin.
Other experiments directly detected the export of
about 30% of internalized ‘‘particulate’’ antigen (lucifer-
ase plus microspheres) from purified phagosomes, in
a process that required both ATP and cytosolic compo-
nents. Although the role of Sec61 in this process was
not examined, the antigen translocation was enhanced
with recombinant p97 and reduced with the dominant-
negative form of p97. Therefore, phagosomes contain
an ERAD-like translocation system.
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antigen-transfer step that underlies the phagosome-
to-cytosol pathway of cross-presentation? They certainly
provide support for a very plausible model (Figure 1).
However, although the experiments clearly show a role
for Sec61 in the cross-presentation of soluble protein,
they do not resolve whether Sec61 is acting in the
phagosome or in the ER. This is because internalized
soluble proteins can be transported retrogradely
through the secretory pathway to the ER (Ackerman
et al., 2005), where they might also be transferred
through Sec61 to the cytosol. Moreover, the Sec 61
mechanism does not easily explain some previous ob-
servations. Specifically, in the X-ray crystal structure of
Sec 61 from M. jannaschii, the protein translocation
channel is only 5–8 A˚ in diameter (Van den Berg et al.,
2004) yet gelonin, peroxidase, and luciferase (proteins
of 30–60 kDa with expected hydrodynamic radii >30 A˚)
are transferred out of phagosomes in intact (i.e., enzy-
matically active) form. These observations suggest that
there could be additional mechanisms that transfer mol-
ecules out of phagosomes. Alternatively, perhaps the
Sec61 channel can widen, as suggested by earlier esti-
mates of up to a 40 A˚ pore, and/or proteins are trans-
ported in an unfolded state and renatured in the cytosol.
Other unresolved questions remain. Ackerman et al.
(2006) provide strong evidence supporting the contro-
versial hypothesis that ER components are present in
phagosomes. This resurrects the initial idea that phago-
somes containing TAP and MHC class I molecules, etc.
may be largely self-contained antigen-presenting or-
ganelles (Figure 1). These vacuoles can import peptides
generated in the cytosol through TAP, and if these were
made by proteasomes associated with their membrane,
the process might be very efficient. However, the
question remains as to whether class I moleculesImmunity 25, October 2006 ª2006 Elsevier Inc. DOI 10.1016/j.immuni.2006.09
Toll-like Receptors Keep
Antigen Sorting on the Right Track
In this issue of Immunity, Yarovinsky et al. (2006) pro-
vide new in vivo insights into the concept that antigen
recognition by TLR is more than APC costimulation
and regulates antigen processing and presentation
to create specific microbial immunity.
One of the enigmas in immunology is how the immune
system manages to maintain nonresponsiveness
against the self during the generation of a neutralizing
immune response against pathogens. The prevailing
concept that pathogens relay danger signals via Toll-like
receptors (TLRs) and that this leads to the maturation of
antigen-presenting cells (APCs) to an immunogenicpredominately acquire cross-presented peptides in
the ER and/or phagosomes (Figure 1). Also unresolved
is how phagosomes acquire the ‘‘ER components’’—is
this by fusion with the ER or some other mechanism(s)?
Finally, we don’t understand what determines whether
an antigen is cross-presented by the phagosome-to-
cytosol pathway versus the cathepsin S-vacuolar path-
way. Thus, Ackerman et al. (2006) have added a piece
to the puzzle of cross-presentation, but maybe not the
final one.
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state is not completely satisfactory because it does not
explain why immunity against coingested self-antigens
does not occur. A much more satisfactory concept al-
ready proposed by Matzinger (Matzinger, 2002) is that
APCs sort antigens into an immunogenic or pathogenic
route on the basis of the presence or absence of danger
signals. However, molecular insights into the basis of
the sorting mechanism has been sketchy thus far.
The discovery of TLRs as pattern-recognition recep-
tors that regulate both innate and adaptive immunity
was the beginning of our understanding of how dendritic
cells (DCs) might discriminate between self and non-self.
The large set of TLRs now cloned recognize highly con-
served chemical structures present on proteins, nucleic
acids, carbohydrates, and lipids. The key characteristics
that distinguish individual TLRs are ligand specificity,
signal-transduction pathways, expression profiles, and
subcellular localization. A common property of TLR
